Page 6 - Diagnosis, management, and surveillance of neurogenic lower urinary tract dysfunction – Full text
P. 6

Kavanagh et al





                                         Focused history, physical exam, PVR, and UA



                       SCI, spina bifida, advanced MS                   Other neurological diseases
                                   All                                  *Selected patients  Most

                               Baseline UDS, renal US, renal function

                                                                                    Optimize bladder
                                   Determine if risk factors are                 management technique,
                                       present based on:                           incontinence, urinary
                                    1. Bladder management                         symptoms, and UTI risk
                                          2. UDS
                                         3. Renal US
                                       4. Renal fuction

                  High-risk                                   Moderate-risk           Low-risk

                                                                                  *Clinically significant PVR
                                   Treatment & Optimization                       Bothersome incontinence
                                                                                  Frequent UTIs
                                                                                  Use of catheters for bladder management
                                                                                  Known high-risk features
                                                                                  Considering more invasive management options
       Fig. 2. Initial investigations and risk stratification for neurogenic lower urinary tract dysfunction (NLUTD) patients. High-risk patients are considered those with
       spinal cord injury (SCI), spina bifida, advanced multiple sclerosis (MS), or select other neurogenic diseases with evidence of significant urological complications
       or morbidity in addition to: 1) bladder management technique: Valsalva/crede/reflexive voiding; or 2) known high-risk features on urodynamics (UDS) without
       confirmation of appropriate attenuation after treatment (detrusor-sphincter dyssynergia [DSD], neurogenic detrusor overactivity [NDO], impaired compliance
       (<20 ml/cmH O), detrusor leak point pressure [DLPP] >40 cmH O, vesico-ureteral reflex); or 3) new/worsening renal imaging (hydronephrosis, atrophy, scarring);
               2
                                              2
       or 4) new/worsening renal insufficiency. Patients with SCI, spina bifida, or advanced MS without high-risk features are considered moderate-risk. PVR: post-void
       residual; UA: urinalysis; US: ultrasound; UTI: urinary tract infection.
       spective study of 73 patients with traumatic SCI followed for   Such secondary VUR may appear as hydroureteronephro-
       a median of 41 years after injury, Elmelund et al found that   sis (HUN) on imaging. Since VUR and HUN may be mani-
       the duration of detrusor contractions (DO/cystometry ratio)   festations of high bladder pressures in neurogenic bladder,
       was associated with renal deterioration. Indeed, patients   treatment should focus first on ensuring low storage pressure.
       with and without renal deterioration had the same maximum   Anti-reflux surgery or double-J ureteral stenting should be
       DLPP (60 cmH O). 40                                   avoided in these cases.
                    2
         Interestingly, increased maximum detrusor pressure dur-  Most agree that some bladder methods (reflex triggering
       ing voiding (75–115 cmH O) has been reported as a risk   and Valsalva or Credé manoeuvres) should be strongly dis-
                              2
       indicator of renal deterioration in SCI patients with NDO. 54,55  couraged due their threat for the upper tract (GOR B, LOE 3).
         Despite the lack of strong evidence identifying risk factors   In some cases, carefully monitored patients may be able to use
       for UUTD, causes for UUTD in neurogenic bladder include   these methods successfully. Clean intermittent catheterization
       bladder outlet obstruction (BOO), ureteral obstruction, UTIs,   (CIC) is a superior method for preserving bladder compliance
       stones and most importantly, persistent high intravesical pres-  compared to chronic suprapubic or urethral catheterization. 2,33
       sures.  High pressures could be from NDO, poor bladder com-  Symptoms of high intravesical pressure are rarely present
            56
       pliance, detrusor-sphincter dyssynergia (DSD) (simultaneous   (e.g., leakage between CIC) and UDS are required to prop-
       detrusor and urinary sphincter contractions), or a combination.   erly identify it. Compliance must be assessed over the range
                                                                                      58
         The pathophysiology of CKD in neurogenic bladder is   typically seen by the bladder.  Despite the fact that patients
       not well-understood. In some cases, it appears that a sus-  with a chronic indwelling catheter have an empty blad-
       tained high storage pressure results in prolonged compres-  der most the time, they still warrant followup for urological
       sion of the ureteric orifices, leading to obstructed urine   complications and hydronephrosis.
       outlet during a prolonged period and, consequently, renal   Overall, patients at higher risk of UUTD are MMC, supra-
                                                                                       2
               57
       damage.  In other situations, high intravesical pressure   sacral SCI, and men with MS.  Clinically stable MS patients
       causes a defective overwhelmed ureterovesical junction   have lower rates of UUTD compared to those with SCI and
       with subsequent VUR and UUTD.                         MMC, even in the setting of DSD. 44

       E162                                       CUAJ • June 2019 • Volume 13, Issue 6
   1   2   3   4   5   6   7   8   9   10   11